For the German chemical giant Bayer, neonicotinoid pesticides—synthetic derivatives of nicotine that attack insects' nervous systems—are big business. In 2010, the company reeled in $789 million euros (more than $1 billion) in revenue from its flagship neonic products imidacloprid and clothianidin. The company's latest quarterly report shows that its "seed treatment" segment—the one that includes neonics—is booming.The nexus of Crop Engineering, Corporate-Funded Research, and Regulation Capture scares the fuck outa me.
And BTW: Ain't no such thing as National Security when it's not safe to breathe the air, drink the water, or eat the food.
No comments:
Post a Comment